Pfizer explores rare disease path.
Shaffer
Catherine
C
D001709:Biotechnology / Q000191:economics; D004345:Drug Industry / Q000191:economics; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics; D018579:Patient Selection; D035583:Rare Diseases / Q000188:drug therapy* / Q000191:economics; D013660:Taxes